Anthony G. Quinn
Overview
Anthony G. Quinn received an average of $3M in total compensation, including $474K in salary, at Aeglea BioTherapeutics from 2017 to 2022.
2022Aeglea BioTherapeuticsFormer President and Chief Executive Officer
2021Aeglea BioTherapeuticsChief Executive Officer
2020Aeglea BioTherapeuticsChief Executive Officer
2019Aeglea BioTherapeuticsChief Executive Officer
2018Aeglea BioTherapeuticsChief Executive Officer
2017Aeglea BioTherapeuticsInterim Chief Executive Officer
Source: SEC filings on October 26, 2023, April 21, 2022, April 23, 2020, April 22, 2019, and April 16, 2018.
Related executives
We found nine more executives who work or worked at Aeglea BioTherapeutics.
Jeffrey Goldberg
Aeglea BioTherapeutics
Chief Executive Officer
Leslie Sloan
Aeglea BioTherapeutics
Chief Operating Officer
Jonathan Alspaugh
Aeglea BioTherapeutics
Chief Financial Officer
Jim Kastenmayer
Aeglea BioTherapeutics
Chief Executive Officer
Michael Hanely
Aeglea BioTherapeutics
Chief Operating Officer
Charles York
Aeglea BioTherapeutics
Chief Financial Officer
James Wooldridge
Aeglea BioTherapeutics
Chief Medical Officer
David Lowe
Aeglea BioTherapeutics
Chief Executive Officer
News
Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
April 17, 2023
Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
April 21, 2022
Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
April 23, 2020
Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
April 22, 2019